Form D Explorer

Form D — Quince Therapeutics, Inc.

0001662774-25-000035 · filed 2025-07-01

Offering

Industry
Biotechnology
Exemptions
06b
Total offering
$21,896,618
Total sold
$11,488,304
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Quince Therapeutics, Inc.
CIK
1662774
Entity
Corporation
Jurisdiction
CALIFORNIA
Year incorporated
—
Address
611 GATEWAY BLVD., SUITE 273
SOUTH SAN FRANCISCO, CA 94080
Phone
(415) 910-5717

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View original on SEC EDGAR.